Table 6 |
|
|
Sensitivity analysis (best estimate)* |
|
|
Potential savings (per inhabitant) |
|
|
|
|
|
Canada |
$146.4 million ($4.68) |
|
France |
$95.3 million ($1.61) |
|
Germany |
$214.1 million ($2.59) |
|
Norway |
$24.1 million ($5.38) |
|
UK |
$199.8 million ($3.36) |
|
US |
$1 340.6 million ($4.86) |
|
|
|
|
* The proportion of the population treated for hypertension increased to 9.4%, and the proportion of patients with hypertension and cardiovascular disease that can take thiazides increased to 40% |
|
|
Fretheim et al. BMC Health Services Research 2003 3:18 doi:10.1186/1472-6963-3-18 |
|
